Purification and partial characterization of plasminogen activator from human uterine tissue
- PMID: 121055
- DOI: 10.1016/0005-2795(79)90205-8
Purification and partial characterization of plasminogen activator from human uterine tissue
Abstract
A procedure was developed for the purification of a plasminogen activator from human uterine tissue. It involves six consecutive steps: (1) extraction of the plasminogen activator from delipidated uterine tissue with 0.3 M potassium acetate buffer, pH 4.2; (2) ammonium sulphate precipitation; (3) zinc chelate-agarose chromatography; (4) n-butyl-agarose chromatography; (5) concanavalin A-agarose chromatography; and (6) gel filtration on Sephadex G-150. The specific activity of the final plasminogen activator preparation was increased by a factor 4500 as compared with the crude extract. The purified plasminogen activator showed a strong tendency to adsorb to surfaces. This could be effectively prevented by Tween-80. The molecular weight of the plasminogen activator was 64 000 as estimated by gel filtration in 1.0 M NaCl and 69 000 as estimated by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulphate. The plasminogen activator consisted of two chains (molecular weights 31 000 and 38 000) connected by disulphide bridges. The smallest chain contained the serine residue of the active site as deduced from the incorporation of the tritium label of [3H]diisopropylphosphofluoridate.
Similar articles
-
Rapid purification of a high-affinity plasminogen activator from human blood plasma by specific adsorption on fibrin/Celite.Proc Natl Acad Sci U S A. 1981 Jul;78(7):4265-9. doi: 10.1073/pnas.78.7.4265. Proc Natl Acad Sci U S A. 1981. PMID: 6270665 Free PMC article.
-
Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.J Biol Chem. 1981 Jul 10;256(13):7035-41. J Biol Chem. 1981. PMID: 6787058
-
Plasminogen-activator in human early milk: its partial purification and characterization.Thromb Haemost. 1981 Apr 30;45(2):121-6. Thromb Haemost. 1981. PMID: 7196095
-
Purification and characterization of human vascular plasminogen activator.Biochim Biophys Acta. 1980 Feb 27;621(2):241-54. doi: 10.1016/0005-2795(80)90176-2. Biochim Biophys Acta. 1980. PMID: 7188733
-
Purifying antibody-plasminogen activator conjugates.Bioconjug Chem. 1992 Jul-Aug;3(4):269-72. doi: 10.1021/bc00016a001. Bioconjug Chem. 1992. PMID: 1390979 Review. No abstract available.
Cited by
-
alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.J Clin Invest. 1987 Nov;80(5):1391-400. doi: 10.1172/JCI113217. J Clin Invest. 1987. PMID: 2445779 Free PMC article.
-
Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies.Tex Heart Inst J. 1991;18(1):50-61. Tex Heart Inst J. 1991. PMID: 15227508 Free PMC article.
-
Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.Biochem J. 1984 May 1;219(3):971-8. doi: 10.1042/bj2190971. Biochem J. 1984. PMID: 6430276 Free PMC article.
-
Localization in the fibrinogen gamma-chain of a new site that is involved in the acceleration of the tissue-type plasminogen activator-catalysed activation of plasminogen.Biochem J. 1992 Apr 1;283 ( Pt 1)(Pt 1):187-91. doi: 10.1042/bj2830187. Biochem J. 1992. PMID: 1567367 Free PMC article.
-
Relationships among the complement, kinin, coagulation, and fibrinolytic systems.Springer Semin Immunopathol. 1983;6(2-3):231-58. doi: 10.1007/BF00205875. Springer Semin Immunopathol. 1983. PMID: 6227099 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources